» Articles » PMID: 15578949

Killing the Messenger: Antisense DNA and SiRNA

Overview
Specialty Pharmacology
Date 2004 Dec 8
PMID 15578949
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Among the technologies available for gene knockdown RNase H-dependent antisense oligonucleotides and RNAi are very popular. Both offer specificity and efficient knockdown of the genes; both are useful tools to study gene functions. Antisense and RNAi methods share many practical problems such as site selection, toxicity at high concentration, and the difficulty of transfection in certain cell types. We will focus in this review on the most important issues in the development of both methods and their possible use in gene-silencing therapy.

Citing Articles

Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells.

Childs-Disney J, Disney M Annu Rev Pharmacol Toxicol. 2015; 56:123-40.

PMID: 26514201 PMC: 4876813. DOI: 10.1146/annurev-pharmtox-010715-103910.


Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity.

Childs-Disney J, Yildirim I, Park H, Lohman J, Guan L, Tran T ACS Chem Biol. 2013; 9(2):538-550.

PMID: 24341895 PMC: 3944380. DOI: 10.1021/cb4007387.


Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1.

Childs-Disney J, Parkesh R, Nakamori M, Thornton C, Disney M ACS Chem Biol. 2012; 7(12):1984-93.

PMID: 23130637 PMC: 3528830. DOI: 10.1021/cb3001606.


Malignant phenotype of PC3 cell line was inhibited by siRNA targeting PAR gene.

Xu X, Zhou S, Zhang Z, Ge J, Cheng W, Wei Z J Huazhong Univ Sci Technolog Med Sci. 2007; 27(4):440-3.

PMID: 17828506 DOI: 10.1007/s11596-007-0423-4.


Alternative initiation and splicing in dicer gene expression in human breast cells.

Irvin-Wilson C, Chaudhuri G Breast Cancer Res. 2005; 7(4):R563-9.

PMID: 15987463 PMC: 1175071. DOI: 10.1186/bcr1043.